(Q39256130)

10 September 2017

title

Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation (English)

1 reference

10 September 2017

K Mizrahi

1

1 reference

10 September 2017

J Stein

2

1 reference

10 September 2017

M Pearl-Yafe

3

1 reference

10 September 2017

O Kaplan

4

1 reference

10 September 2017

I Yaniv

5

1 reference

10 September 2017

N Askenasy

6

1 reference

10 September 2017

publication date

20 May 2010

1 reference

10 September 2017

1 reference

10 September 2017

volume

24

1 reference

10 September 2017

issue

7

1 reference

10 September 2017

page(s)

1325-1334

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.97

10 September 2017

exact match

0 references

cites work

Signalling pathways of the TNF superfamily: a double-edged sword

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Targeting TRAIL agonistic receptors for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

The role of TRAIL death receptors in the treatment of hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

TRAIL receptor signalling and modulation: Are we on the right TRAIL?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

The signaling adaptors and pathways activated by TNF superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Regulation of proliferation, survival and apoptosis by members of the TNF superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

TRAIL signalling: decisions between life and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Death receptor signal transducers: nodes of coordination in immune signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

TRAIL regulates normal erythroid maturation through an ERK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Ex vivo purging of leukemia cells using tumor-necrosis-factor-related apoptosis-inducing ligand in hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

A probable role for trail-induced apoptosis in the pathogenesis of marrow failure. Implications from an in vitro model and from marrow of aplastic anemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Tuning the rheostat of the myelopoietic system via Fas and TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Apoptotic mechanisms in the control of erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Human-Hemato-Lymphoid-System Mice: Opportunities and Challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Reduced-intensity conditioning in children: a reappraisal in 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Consideration of strategies for hematopoietic cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

7 January 2021

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

7 January 2021

T cells require TRAIL for optimal graft-versus-tumor activity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

7 January 2021

Characterization of human hematopoietic cells with short-lived in vivo repopulating activity.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.97

7 January 2021

Identifiers

DOI

10.1038/LEU.2010.97

1 reference

release_f3b2w5iyyrervhvwcs4e2foim4

10 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f3b2w5iyyrervhvwcs4e2foim4

24 November 2022

mapped directly with Wikidata item

1 reference